TrialSite News
About this raise: TrialSite News, with a valuation of $11.8 million, is raising funds on PicMii. The company provides unbiased, objective, and independent media and analysis to medical research. The business publishes complex medical research for its subscribers, including physicians, healthcare professionals, patients, and investors. TrialSite News is a social and media network dedicated to medical research. The business is expected to reach 10,000 subscribers and $500,000 to $1 million in revenue by the end of 2022. Daniel O’Conner founded TrialSite News in April 2021. The current crowdfunding campaign has a minimum target of $50,001 and a maximum target of $249,998.70. The campaign proceeds will be used to add more subscribers and generate more revenues.
Investment Overview
Invested $59,250 :
Deal Terms
Company & Team
Company
- Year Founded
- 2021
- Industry
- Media, Entertainment & Publishing
- Tech Sector
- Distribution Model
- B2C
- Margin
- Low
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $0
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
11/30/2022 | PicMii | $11,600,637 | $59,250 | Equity - Common | Funded | RegCF |